Brokerages expect that CryoPort Inc (NASDAQ:CYRX) will report earnings of ($0.07) per share for the current quarter, according to Zacks. Three analysts have provided estimates for CryoPort’s earnings, with the lowest EPS estimate coming in at ($0.08) and the highest estimate coming in at ($0.04). CryoPort reported earnings per share of ($0.12) during the same quarter last year, which would suggest a positive year over year growth rate of 41.7%. The firm is scheduled to announce its next earnings results on Monday, March 12th.
According to Zacks, analysts expect that CryoPort will report full-year earnings of ($0.32) per share for the current fiscal year, with EPS estimates ranging from ($0.34) to ($0.29). For the next year, analysts expect that the business will post earnings of ($0.23) per share, with EPS estimates ranging from ($0.26) to ($0.18). Zacks’ earnings per share calculations are a mean average based on a survey of analysts that follow CryoPort.
CryoPort (NASDAQ:CYRX) last issued its earnings results on Wednesday, November 1st. The consumer goods maker reported ($0.08) EPS for the quarter, hitting analysts’ consensus estimates of ($0.08). CryoPort had a negative net margin of 91.28% and a negative return on equity of 46.99%.
Institutional investors and hedge funds have recently made changes to their positions in the stock. Northern Trust Corp lifted its position in CryoPort by 105.0% in the second quarter. Northern Trust Corp now owns 22,179 shares of the consumer goods maker’s stock valued at $109,000 after acquiring an additional 11,358 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank purchased a new stake in CryoPort in the third quarter valued at $118,000. Bank of Montreal Can purchased a new stake in CryoPort in the fourth quarter valued at $142,000. Wolverine Trading LLC purchased a new stake in CryoPort in the third quarter valued at $230,000. Finally, Granite Investment Partners LLC purchased a new stake in CryoPort in the third quarter valued at $535,000. 18.10% of the stock is owned by hedge funds and other institutional investors.
CryoPort (NASDAQ CYRX) opened at $8.36 on Friday. The company has a market cap of $214.54, a price-to-earnings ratio of -16.39 and a beta of 0.99. CryoPort has a 12 month low of $1.96 and a 12 month high of $10.40.
Cryoport, Inc (Cryoport) is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Company provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with MarketBeat.com's FREE daily email newsletter.